Case Report
BibTex RIS Cite

Didrogesterona bağlı toksik hepatit: Olgu sunumu

Year 2020, Volume: 4 Issue: 1, 21 - 23, 23.04.2020
https://doi.org/10.46332/aemj.626178

Abstract

43 yaşında kadın hasta acil servise karın ağrısı, sarılık ve idrar renginde koyulaşma şikâyeti ile başvurdu. Hastanın adet düzensizliği nedeniyle bir ay didrogesteron preperatı aldığı öğrenildi. Labaratuar değerlerinde karaciğer enzimlerinde yükseklik saptanan ve diğer etyolojik faktörler dışlanan hastada ilaca bağlı toksik hepatit düşünüldü. Hastaya karaciğer biyopsisi yapıldı, biyopsi sonucu toksik hepatit ile uyumlu gelen hastanın ilacı kesildi ve hastaya destek tedavisi başlandı. Takipte enzimleri ve kliniği düzelen hasta önerilerle taburcu edildi. Didrogesteron her ne kadar güvenli bir ilaç olarak bilinse de ilaç kullanımında sarılık gelişen hastalarda ilacın indüklediği toksik hepatit akla gelmelidir.

References

  • 1. Coelingh Bennink HJ, Boerrigter PJ. Use of dydrogesterone as a progestogen for oral contraception. Steroids. 2003;68(10-13):927-929.
  • 2. Altintaş E, Oğuz D, Kaçar S, Ozderin Y, Sezgin O, Zengin NI. Dydrogesterone-induced hepatitis and autoimmune hemolytic anemia. Turk J Gastroenterol. 2004;15(1):49-52.
  • 3. Franco Hidalgo S, Prieto de Paula JM, Salado Valdivieso I. Toxic hepatitis associated with the use of medroxyprogesterone. Gastroenterol Hepatol. 2009;32(1):72-73.
  • 4. Arıcı S. Toksik Hepatit. Pamukkale Tıp Dergisi. 2008;1(2):113-119.
  • 5. Chitturi S. Farrell G.C. Drug Induced Liver Injury. In Schiff ER, Sorrell MF, Maddrey WC. Schiff's Diseases of Liver. 10th ed. United States: John Wiley and Sons, Inc; 2011:923–1003.
  • 6. Hee L, Kettner LO, Vejtorp M. Continuous use of oral contraceptives: an overview of effects and side-effects. Acta Obstet Gynecol Scand. 2013;92(2):125-136.
  • 7. Choudhary NS, Bodh V, Chaudhari S, Saraf N, Saigal S. Norethisterone Related Drug Induced Liver Injury: A Series of 3 Cases. J Clin Exp Hepatol. 2017;7(3):266-268.
  • 8. Andrade RJ, Chalasani N, Björnsson ES, ve ark. Drug-induced liver injury. Nat Rev Dis Primers. 2019;5(1):58.

Didrogesterone-Induced Toxic Hepatitis: A Case Report

Year 2020, Volume: 4 Issue: 1, 21 - 23, 23.04.2020
https://doi.org/10.46332/aemj.626178

Abstract

43 years old female patient admitted to our clinic with icter, abdominal pain and darkness in urine. It was learned that she used a didrogesterone preparation for one month due to menstrual irregularity. Drug-induced toxic hepatitis was considered in the patient whose liver enzymes were increased and other etiological factors were excluded. Liver biopsy was performed and the biopsy was compatible with toxic hepatitis. The drug was discontinued and supportive treatment was initiated. At follow up liver enzymes regressed and patient discharged. Although didrogesterone is known to be a safe drug, drug-induced toxic hepatitis should be considered in cases of jaundice.

References

  • 1. Coelingh Bennink HJ, Boerrigter PJ. Use of dydrogesterone as a progestogen for oral contraception. Steroids. 2003;68(10-13):927-929.
  • 2. Altintaş E, Oğuz D, Kaçar S, Ozderin Y, Sezgin O, Zengin NI. Dydrogesterone-induced hepatitis and autoimmune hemolytic anemia. Turk J Gastroenterol. 2004;15(1):49-52.
  • 3. Franco Hidalgo S, Prieto de Paula JM, Salado Valdivieso I. Toxic hepatitis associated with the use of medroxyprogesterone. Gastroenterol Hepatol. 2009;32(1):72-73.
  • 4. Arıcı S. Toksik Hepatit. Pamukkale Tıp Dergisi. 2008;1(2):113-119.
  • 5. Chitturi S. Farrell G.C. Drug Induced Liver Injury. In Schiff ER, Sorrell MF, Maddrey WC. Schiff's Diseases of Liver. 10th ed. United States: John Wiley and Sons, Inc; 2011:923–1003.
  • 6. Hee L, Kettner LO, Vejtorp M. Continuous use of oral contraceptives: an overview of effects and side-effects. Acta Obstet Gynecol Scand. 2013;92(2):125-136.
  • 7. Choudhary NS, Bodh V, Chaudhari S, Saraf N, Saigal S. Norethisterone Related Drug Induced Liver Injury: A Series of 3 Cases. J Clin Exp Hepatol. 2017;7(3):266-268.
  • 8. Andrade RJ, Chalasani N, Björnsson ES, ve ark. Drug-induced liver injury. Nat Rev Dis Primers. 2019;5(1):58.
There are 8 citations in total.

Details

Primary Language Turkish
Subjects Clinical Sciences
Journal Section Case Reports
Authors

Mustafa Kaplan 0000-0002-6959-675X

Muhammet Yener Akpınar 0000-0003-0903-4664

Orhan Coşkun 0000-0002-3124-9517

Adem Aksoy This is me 0000-0003-3823-3654

Volkan Gökbulut 0000-0002-7906-2479

Publication Date April 23, 2020
Published in Issue Year 2020 Volume: 4 Issue: 1

Cite

APA Kaplan, M., Akpınar, M. Y., Coşkun, O., Aksoy, A., et al. (2020). Didrogesterona bağlı toksik hepatit: Olgu sunumu. Ahi Evran Medical Journal, 4(1), 21-23. https://doi.org/10.46332/aemj.626178
AMA Kaplan M, Akpınar MY, Coşkun O, Aksoy A, Gökbulut V. Didrogesterona bağlı toksik hepatit: Olgu sunumu. Ahi Evran Med J. April 2020;4(1):21-23. doi:10.46332/aemj.626178
Chicago Kaplan, Mustafa, Muhammet Yener Akpınar, Orhan Coşkun, Adem Aksoy, and Volkan Gökbulut. “Didrogesterona bağlı Toksik Hepatit: Olgu Sunumu”. Ahi Evran Medical Journal 4, no. 1 (April 2020): 21-23. https://doi.org/10.46332/aemj.626178.
EndNote Kaplan M, Akpınar MY, Coşkun O, Aksoy A, Gökbulut V (April 1, 2020) Didrogesterona bağlı toksik hepatit: Olgu sunumu. Ahi Evran Medical Journal 4 1 21–23.
IEEE M. Kaplan, M. Y. Akpınar, O. Coşkun, A. Aksoy, and V. Gökbulut, “Didrogesterona bağlı toksik hepatit: Olgu sunumu”, Ahi Evran Med J, vol. 4, no. 1, pp. 21–23, 2020, doi: 10.46332/aemj.626178.
ISNAD Kaplan, Mustafa et al. “Didrogesterona bağlı Toksik Hepatit: Olgu Sunumu”. Ahi Evran Medical Journal 4/1 (April 2020), 21-23. https://doi.org/10.46332/aemj.626178.
JAMA Kaplan M, Akpınar MY, Coşkun O, Aksoy A, Gökbulut V. Didrogesterona bağlı toksik hepatit: Olgu sunumu. Ahi Evran Med J. 2020;4:21–23.
MLA Kaplan, Mustafa et al. “Didrogesterona bağlı Toksik Hepatit: Olgu Sunumu”. Ahi Evran Medical Journal, vol. 4, no. 1, 2020, pp. 21-23, doi:10.46332/aemj.626178.
Vancouver Kaplan M, Akpınar MY, Coşkun O, Aksoy A, Gökbulut V. Didrogesterona bağlı toksik hepatit: Olgu sunumu. Ahi Evran Med J. 2020;4(1):21-3.

Ahi Evran Medical Journal  is indexed in ULAKBIM TR Index, Turkish Medline, DOAJ, Index Copernicus, EBSCO and Turkey Citation Index. Ahi Evran Medical Journal is periodical scientific publication. Can not be cited without reference. Responsibility of the articles belong to the authors.

    Creative Commons Lisansı

This journal is licensed under the Creative Commons Atıf-GayriTicari 4.0 Uluslararası Lisansı.